Table 1.
Parameter | Goiter | Autoimmune thyroiditis | Thyroid carcinoma | P-value* |
---|---|---|---|---|
Patients (n) | 111 | 95 | 136 | – |
Gender (female/male) | 83/17% | 92/8% | 71/29% | <0.001 |
Age (years) | 59.5 (12.1) | 51.9 (15.8) | 54.6 (14.1) | <0.001 |
BMI (kg/m2) | 26.8 [24.2, 30.8] |
27.2 [23.5, 29.7] |
28.3 [24.8, 33.0] |
<0.001 |
Weight adjusted LT4 dose (μg/kg BW /day) |
1.11 [0.88, 1.47] |
1.27 [0.95, 1.67] |
1.69 [1.52, 2.01] |
<0.001 |
FT3 (pmol/l) | 4.76 (0.52) | 4.62 (0.56) | 5.09 (0.72) | <0.001 |
FT4 (pmol/l) | 17.15 [15.9, 19.6] |
17.0 [15.1, 18.9] |
20.4 [18.6, 22.8] |
<0.001 |
TSH (mIU/l) | 0.81 [0.42, 1.27] |
1.32 [0.57, 2.04] |
0.17 [0.03, 0.88] |
<0.001 |
P-values were derived by ANOVA or, in case of non-normally distributed parameters, Kruskal-Wallis test.